Splicing is a key process for mRNA maturation, particularly in higher eukaryotes where most protein-coding transcripts contain multiple introns. It is achieved by the concerted action of five snRNAs (small nuclear RNAs) and hundreds of accessory proteins that form the spliceosome. Although snRNAs are present in equal amounts in the spliceosome, there is an overall excess of U1 in human cells. This finding led to the opinion that U1 might be involved in processes other than splicing. Research has shown that this is indeed the case and some examples found from studies in human cell systems are described briefly in the present review.
U1 snRNP (small nuclear ribonucleoprotein) complex
Human U1 snRNA (small nuclear RNA) is 164 nt long with a well-defined structure consisting of four stem-loops [1, 2] . It is normally part of an RNP (ribonucleoprotein) complex (termed U1 snRNP) containing seven Sm proteins as well as U1A, U1C and U1-70k [3] . The conventional function for U1 snRNA is in splicing [4] . Specifically, U1 is required at the very first stage of the splicing process [5] . The 5 -end of U1 snRNA contains a short sequence that is broadly complementary to the 5 -SSs (5 -splice sites) of introns. Base pairing between these two sequences plays a key role in the initiation of splicing and in marking the 5 -end of an intron [6] .
U1 in early transcriptional events
The presence of introns has long been known to enhance gene output. For example, the expression of transgenes in mice was enhanced 10-100-fold by the presence of introns [7, 8] . Some of the enhancing effects of introns on gene expression are explained by an association of the exonjunction complex with mRNA following splicing, which increases translation efficiency [9] . However, a promoterproximal 5 -SS is also implicated in this effect [10] . Point mutations in this sequence of an HIV-1 minigene construct reduced the level of transcription when measured by nuclear run-on analysis [10] . The same study demonstrated that exogenous U1 engineered to bind to the mutant premRNA transcript restored correct levels of transcription, implicating the U1-pre-mRNA interaction in the process. Finally, the proximity of the 5 -SS to the promoter is also a vital component of the enhancement mechanism since transcription was progressively reduced as the distance between the two elements was increased. Although these earlier experiments were based on plasmid gene templates, they were corroborated by a study on mutant genes integrated into chromosomes [11] . These more recent data showed that, as well as reducing RNA Pol II (polymerase II) occupancy on a gene, 5 -SS mutations also resulted in reduced recruitment of TBP (TATA-box-binding protein), TFIIB (transcription factor IIB) and TFIIH (transcription factor IIH) to promoters and depletion of some active histone marks.
The connections between a promoter-proximal 5 -SS, U1 and the transcription initiation machinery have also been dissected in vitro, where U1 snRNA was shown to interact with the general initiation factor TFIIH [12] . The functional relevance of this interaction is in stimulating the formation of the first phosphodiester bond following initiation. Furthermore, a 5 -SS enhanced TFIIH-dependent re-initiation in reconstituted assays. Thus, through a combination of interactions with the pre-mRNA transcript and with the transcription initiation machinery, U1 snRNA plays a key role in early transcriptional events.
There is also evidence of other roles for U1 in transcription that may not depend on its interaction with pre-mRNA. For instance, U1 snRNA that cannot function in splicing is still recruited to active transcription units in Xenopus oocytes [13] . Moreover, U1 is the only snRNA found to associate with intronless genes or genes mutated to inactivate splicing [14, 15] .
Different types of U1 snRNP in human cells
Consistent with it playing multiple roles in transcription, two groups have recently identified a fraction of U1 snRNA in association with the transcription factor TAF15 [16, 17] . Interestingly, one group found this new snRNP to be devoid of conventional U1-binding factors such as U1-70k [17] . A second group also found U1 snRNA in association with TAF15, but this time U1-70k and the Sm proteins were present [16] . These findings highlight the existence of a further two U1 snRNP complexes, both with TAF15 and one with which canonical U1 snRNP components do not associate.
The function(s) of these new snRNPs is yet to be determined, but they are present in chromatin fractions, indicating roles in transcription.
U1 regulates 3 -end processing of viral RNA
One of the best known functions for U1 snRNA outside splicing is in the regulation of 3 -end processing and specifically its suppression. Early work on BPV (bovine papillomavirus) transcription identified an element within the 3 -UTR (untranslated region) that repressed the level of transcripts derived from processing of the late pA [poly(A)] signal [18] . Further dissection revealed a 5 -SS-like sequence, implicating U1 in the process [19] . Subsequent in vitro analysis of this regulation showed that binding of U1 snRNP does not inhibit cleavage at the pA [20] . Instead, through a direct interaction between its U1-70k component and pA polymerase, U1 inhibits polyadenylation following successful cleavage of the BPV pA signal. It is now well established that inefficient polyadenylation leaves RNAs highly susceptible to degradation by the exosome [21] [22] [23] [24] . It seems likely, although not formally shown, that this is the fate of transcripts regulated in this fashion.
Other viruses also utilize U1 to regulate synthesis of their RNAs. The HIV proviral genome is flanked by two highly similar LTRs (long terminal repeats). Both LTR regions contain a pA signal but only the promoter distal one is processed. Although promoter proximity often precludes pA site cleavage [25] , a heterologous pA site was shown to function in place of the 5 -LTR [26] . Instead of its position, the critical feature for suppression turned out to be the presence of a 5 -SS (the major splice donor site) located shortly downstream. Corroborating this assertion, mutation of the SS activated the pA site, which could in turn be silenced again by use of U1 engineered to bind the mutant transcript [26, 27] .
As discussed above, inhibition of pA polymerase by U1-70k suppresses the BPV late pA signal by preventing polyadenylation of the cleaved RNA. This would be a poor strategy for the HIV provirus because cleavage of the promoter proximal pA site would render vital downstream transcripts vulnerable to exonucleolytic degradation. There must therefore be distinct mechanisms of pA suppression by U1 in these two systems. The major difference between the two transcripts at the RNA sequence level is the arrangement of 5 -SS and pA signal. In BPV, the 5 -SS precedes the pA signal whereas in the HIV 5 -LTR it follows it. This arrangement is an important determinant of the inhibitory mechanism because, though a 5 -SS upstream of the pA inhibits polyadenylation, one positioned beyond a pA signal inhibits the cleavage step [28] . Interestingly, the same in vitro system indicated that U1-70k is not involved in cleavage inhibition. However, an independent study found that the region of U1 to which U1-70k binds was required for suppression of the HIV 5 -LTR pA site in vivo [29] .
Parameters for pA site suppression by U1
It is straightforward to target U1 to any RNA of interest by replacing the short sequence normally responsible for 5 -SS interaction with any region complementary to a transcript of interest [30] [31] [32] [33] . In addition to offering the potential for mRNA knockdown studies, this approach has been used to dissect the requirements for polyadenylation inhibition by U1. The most stringent requirement is that the binding site be present in the terminal exon as a downstream intron completely alleviates suppression [30] . In reporter constructs, effective inhibition of processing was observed with U1 targeted at various positions up to 1 kb upstream of the pA site, implying only loose distance constraints. A region of 8-16 nt of base pairing between U1 and the target RNA gives maximal repression with longer regions for some reason losing their effectiveness [3] . Interestingly, polyadenylation of RNA can be inhibited by U1-70k (and U1A) independently of U1 snRNA by tethering the proteins upstream of a pA signal using the MS2 system [34] . Other proteins, including U2AF65, possessing serine/arginine-rich regions also prevented polyadenylation activity in this system [34] . Although it would be interesting to do so, the mechanism by which pA cleavage is inhibited by a downstream 5 -SS has not been investigated in the same detail.
U1 snRNA protects human pre-mRNA from premature 3 -end processing A pA signal, from what we know, is a very simple sequence. The basic sequence requirements are an AAUAAA hexamer (though other similar hexamers may also function) followed by a short U-or G/U-rich region [35, 36] . Potentially functional pA signals abound in pre-mRNAs of complex transcriptomes. For example, the average human proteincoding gene is ∼25-30 kb and may well contain multiple pA sites in addition to the active sequence at the 3 -end. Most of these are likely to be intronic given that the majority of most pre-mRNA is intron sequence. However, there is clearly no preponderance of 3 -end processing within introns, implying that such pA signals are often non-functional, produce unstable RNA or are frequently silenced. Interestingly, a strong SPA (synthetic pA) site is inactive when placed within an intron, arguing for a mechanism by which bone fide pA signals are silenced in a location-dependent manner [37] . Thus, in common with some of the viral RNAs discussed above, transcription of such long transcripts presents the problem of selecting the correct pA signal while ignoring premature sequences.
A recent study by Dreyfuss and co-workers shows that striking similarities do in fact exist between human and viral genes [38] . To study the global consequences of U1 snRNA inactivation, they used a morpholino oligonucleotide designed to block its 5 -SS interaction region. The basic expectation of this treatment would be to generally stabilize intronic RNA due to the anticipated block of splicing. Instead, a tiling array-based approach revealed widespread stabilization of promoter-proximal intron regions followed by a sharp reduction in RNA 3 of these positions. Subsequent 3 -RACE (rapid amplification of cDNA ends) analysis of these stabilized RNAs revealed the presence of pA tails shortly downstream of canonical AAUAAA sequences present in introns. Cloning of one of the regions of premature 3 -end processing into a mini-gene context demonstrated a need for a functional 5 -SS and AAUAAA hexamer, which firmly implements U1 snRNA and conventional cleavage and polyadenylation [38] . Finally, inhibition of splicing at steps subsequent to U1 binding did not result in this effect, strongly suggesting that it is not an indirect consequence of splicing inhibition. In summary, the absence of effective U1-RNA interaction caused widespread premature cleavage and polyadenylation of pre-mRNA transcripts. The authors sensibly propose that many sequences within pre-mRNA that resemble a 5 -SS are bound by U1, even if these sites are not functionally important in terms of splicing. The purpose of this widespread U1 binding is to protect pre-mRNA from premature 3 -end processing, which is obviously vital for the correct transcript to be synthesized. The large number of 5 -SS-like sequences may offer an explanation for the abundance of U1 in human cells.
It is not yet known, however, whether these sites are bound by free U1 or whether Pol II-associated U1 binds more effectively. It should be noted in this regard that U1 strongly associates with Pol II, as observed by immunoprecipitation [39] . An interesting question concerns how the negative influence of U1 is avoided to allow processing at the correct pA signals. Splicing, which is now thought to be mostly co-transcriptional [40, 41] , would be an obvious means of removing intron-bound U1. However, sequences conducive to inhibition may well be exposed in the terminal exon or within the 3 -flank into which Pol II transcribes before pA cleavage takes place [42, 43] . U1 binding might therefore have to be prevented over a large region so that proper cleavage and polyadenylation is not blocked. This may be achieved through a paucity of potential U1-binding sites but this theory requires verification.
Summary
From its key role in transcription initiation and maintenance of elongation through to its regulatory function in 3 -end formation, U1 snRNA is a fascinating non-coding transcript. In the more immediate future, it will be interesting to learn more about how U1 protects pre-mRNA from premature cleavage and polyadenylation and if further mechanistic similarity with the viral RNA transcripts exists. Further, insights are also required into how U1 inhibition of 3 -end formation is circumvented to achieve proper 3 -end formation. Finally, it will be intriguing to discover how many RNPs contain U1 snRNA and what their functions are. The coming years will no doubt yield more secrets about U1 snRNA and further expand its repertoire.
